Europe Botanical and Plant-Derived Drugs Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Botanical and Plant-Derived Drugs Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Terpenes and Steroids Market Performance (Volume)
  • 2.1.2 Alkaloids and Glycosides Market Performance (Volume)
  • 2.1.3 Phenols Market Performance (Volume)
  • 2.1.4 Other Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Terpenes and Steroids Market Performance (Value)
  • 2.1.2 Alkaloids and Glycosides Market Performance (Value)
  • 2.1.3 Phenols Market Performance (Value)
  • 2.1.4 Other Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Poultry Market Performance (Volume)
  • 3.1.2 Fisheries Market Performance (Volume)
  • 3.1.3 Fruits and Vegetables Market Performance (Volume)
  • 3.1.4 Other Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Yunnan Baiyao
  • 4.1.1 Yunnan Baiyao Profiles
  • 4.1.2 Yunnan Baiyao Product Information
  • 4.1.3 Yunnan Baiyao Botanical and Plant-Derived Drugs Business Performance
  • 4.1.4 Yunnan Baiyao Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.2 Tongrentang
  • 4.2.1 Tongrentang Profiles
  • 4.2.2 Tongrentang Product Information
  • 4.2.3 Tongrentang Botanical and Plant-Derived Drugs Business Performance
  • 4.2.4 Tongrentang Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.3 TASLY
  • 4.3.1 TASLY Profiles
  • 4.3.2 TASLY Product Information
  • 4.3.3 TASLY Botanical and Plant-Derived Drugs Business Performance
  • 4.3.4 TASLY Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.4 Sanjiu
  • 4.4.1 Sanjiu Profiles
  • 4.4.2 Sanjiu Product Information
  • 4.4.3 Sanjiu Botanical and Plant-Derived Drugs Business Performance
  • 4.4.4 Sanjiu Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.5 Zhongxin
  • 4.5.1 Zhongxin Profiles
  • 4.5.2 Zhongxin Product Information
  • 4.5.3 Zhongxin Botanical and Plant-Derived Drugs Business Performance
  • 4.5.4 Zhongxin Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.6 Haiyao
  • 4.6.1 Haiyao Profiles
  • 4.6.2 Haiyao Product Information
  • 4.6.3 Haiyao Botanical and Plant-Derived Drugs Business Performance
  • 4.6.4 Haiyao Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.7 Taiji
  • 4.7.1 Taiji Profiles
  • 4.7.2 Taiji Product Information
  • 4.7.3 Taiji Botanical and Plant-Derived Drugs Business Performance
  • 4.7.4 Taiji Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.8 Kunming Pharma
  • 4.8.1 Kunming Pharma Profiles
  • 4.8.2 Kunming Pharma Product Information
  • 4.8.3 Kunming Pharma Botanical and Plant-Derived Drugs Business Performance
  • 4.8.4 Kunming Pharma Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.9 JZJT
  • 4.9.1 JZJT Profiles
  • 4.9.2 JZJT Product Information
  • 4.9.3 JZJT Botanical and Plant-Derived Drugs Business Performance
  • 4.9.4 JZJT Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.10 Guangzhou Pharma
  • 4.10.1 Guangzhou Pharma Profiles
  • 4.10.2 Guangzhou Pharma Product Information
  • 4.10.3 Guangzhou Pharma Botanical and Plant-Derived Drugs Business Performance
  • 4.10.4 Guangzhou Pharma Botanical and Plant-Derived Drugs Business Development and Market Status
• 4.11 Tsumura
• 4.12 Schwabe
• 4.13 TASLY
• 4.14 Sanjiu
• 4.15 Zhongxin

5 Market Performance for Manufacturers

• 5.1 Europe Botanical and Plant-Derived Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Europe Botanical and Plant-Derived Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Europe Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Europe Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Germany Market Performance for Manufacturers
  • 6.1.1 Germany Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 Germany Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 Germany Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 Germany Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 UK Market Performance for Manufacturers
  • 6.2.1 UK Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 UK Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 UK Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 UK Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 France Market Performance for Manufacturers
  • 6.3.1 France Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 France Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 France Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 France Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Russia Market Performance for Manufacturers
  • 6.4.1 Russia Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Russia Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Russia Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Russia Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 Benelux Market Performance for Manufacturers
  • 6.5.1 Benelux Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 Benelux Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 Benelux Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 Benelux Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Italy Market Performance for Manufacturers
  • 6.6.1 Italy Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Italy Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Italy Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Italy Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Spain Market Performance for Manufacturers
  • 6.7.1 Spain Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Spain Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Spain Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Spain Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Botanical and Plant-Derived Drugs Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Botanical and Plant-Derived Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Botanical and Plant-Derived Drugs Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Botanical and Plant-Derived Drugs Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Europe Botanical and Plant-Derived Drugs Market Performance (Sales Point)

• 7.1 Europe Botanical and Plant-Derived Drugs Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Europe Botanical and Plant-Derived Drugs Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Europe Botanical and Plant-Derived Drugs Price (USD/Unit) by Regions 2013-2018
• 7.4 Europe Botanical and Plant-Derived Drugs Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Europe Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 Germany Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 UK Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 France Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Russia Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 Benelux Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Italy Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Spain Botanical and Plant-Derived Drugs Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Poultry Industry
• 11.2 Fisheries Industry
• 11.3 Fruits and Vegetables Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Europe Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Europe Botanical and Plant-Derived Drugs Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 Germany Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 UK Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 France Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Russia Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 Benelux Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Italy Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Spain Botanical and Plant-Derived Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Terpenes and Steroids Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Alkaloids and Glycosides Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Phenols Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Other Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Poultry Sales and and Growth Rate 2019-2024
  • 12.4.3 Fisheries Sales and and Growth Rate 2019-2024
  • 12.4.4 Fruits and Vegetables Sales and and Growth Rate 2019-2024
  • 12.4.5 Other Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Europe Botanical and Plant-Derived Drugs Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Europe Botanical and Plant-Derived Drugs Gross Profit Trend 2019-2024

13 Conclusion